Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Pancreatitis, Alcoholic 1Pancreatitis 1Fibrosis 1Erectile Dysfunction 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 908Carboplatin 785Paclitaxel 739pembrolizumab 738Cisplatin 707Bevacizumab 705Gemcitabine 619Docetaxel 578Rituximab 548Radiotherapy 539Dexamethasone 510Nivolumab 485Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 357Pemetrexed 334Cytarabine 334Oxaliplatin 333Lenalidomide 327Prednisone 326fludarabine phosphate 315Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Has results × Pentoxifylline × Clear all
NCT03830164 2023-10-17

Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
14 enrolled 9 charts

Erectile Dysfunction

NCT01508221 2023-09-14

Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis

University of Cincinnati

Phase 2 Completed
31 enrolled 8 charts
CNS

Brain Neoplasms

NCT02487225 2019-01-23

AP

Mayo Clinic

Phase 3 Completed
83 enrolled 11 charts

Pancreatitis, Pancreatitis, Alcoholic

NCT00583700 2013-01-29

Trental & Vitamin E for Radiation-Induced Fibrosis

University of Iowa

Phase 2 Completed
54 enrolled 7 charts
Breast

Breast Neoplasms, Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡